(Unaudited) |
|
|||||||
June 30 |
December 31 |
|||||||
2023 |
2022 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash, current |
— | |||||||
Accounts receivable, net |
||||||||
Contract assets |
||||||||
Prepaid expenses |
||||||||
Other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
|
|
|
|
|||||
Property and equipment, net |
||||||||
Intangible assets, net |
||||||||
Operating lease right of use assets |
||||||||
Goodwill |
||||||||
Investments |
||||||||
Restricted cash, non-current |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ |
$ |
||||||
|
|
|
|
|||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Deferred revenue |
||||||||
Current debt |
||||||||
Derivative warrant liabilities |
— | |||||||
Operating lease liabilities, current |
||||||||
Other current liabilities |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
|
|
|
|
|||||
Long-term debt – less current portion |
||||||||
Deferred tax liability |
||||||||
Operating lease liabilities, non-current |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies (Note 16) |
||||||||
Shareholders’ equity |
||||||||
Common stock, $ |
||||||||
B Shares, $ |
||||||||
Additional paid-in capital |
||||||||
Treasury stock, at cost, |
( |
) | — | |||||
Accumulated deficit |
( |
) | ( |
) | ||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total shareholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities and shareholders’ equity |
$ |
$ |
||||||
|
|
|
|
Three Months Ended |
Six Months Ended |
|||||||||||||||
June 30, |
June 30, |
|||||||||||||||
2023 |
2022 |
2023 |
2022 |
|||||||||||||
Revenue |
$ | $ | $ | $ | ||||||||||||
Cost of revenue |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit (loss) |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses: |
||||||||||||||||
Sales and marketing |
||||||||||||||||
Research and development |
||||||||||||||||
General and administrative |
||||||||||||||||
Transaction expenses |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expense |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Interest (expense) income, net |
( |
) | ( |
) | ( |
) | ||||||||||
Loss on disposal of assets |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
(Loss) gain on fair value remeasurement of contingent consideration |
( |
) | ( |
) | ||||||||||||
Change in fair value of derivative warrant liabilities |
( |
) | ||||||||||||||
Gain on foreign currency |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other income (expense) |
( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Loss before income taxes |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Income tax (expense) benefit |
( |
) | ( |
) | ( |
) | ||||||||||
Gain from equity method investment |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||
|
|
|
|
|
|
|
|
|||||||||
Loss per share attributable to common stockholders: |
||||||||||||||||
Basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Weighted average common stock outstanding: |
||||||||||||||||
Basic and diluted |
Three Months Ended |
Six Months Ended |
|||||||||||||||
June 30, |
June 30, |
|||||||||||||||
2023 |
2022 |
2023 |
2022 |
|||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Other comprehensive income (loss): |
||||||||||||||||
Foreign currency translation adjustments |
( |
) | ( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive income (loss) |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||||
|
|
|
|
|
|
|
|
Common Stock |
Amounts |
B Shares |
Amounts |
Additional Paid in Capital |
Treasury Stock |
Amounts |
Accumulated Deficit |
Accumulated Other Comprehensive Loss |
Total Shareholders’ Equity |
|||||||||||||||||||||||||||||||
Balance at January 1, 2023 |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Vesting of shares |
— | — | ( |
) | — | — | — | — | — | |||||||||||||||||||||||||||||||
Issuance of common stock in connection with business combinations |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Issuance (acquisition) of common shares in connection with warrant redemptions |
— | — | ( |
) | ( |
) | — | — | ||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance at March 31, 2023 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Vesting of shares |
— | — | ( |
) | — | — | — | — | — | |||||||||||||||||||||||||||||||
Issuance of common stock in connection with business combinations |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance at June 30, 2023 |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Common Stock |
Amounts |
B Shares |
Amounts |
Additional Paid in Capital |
Treasury Stock |
Amounts |
Accumulated Deficit |
Accumulated Other Comprehensive Loss |
Total Shareholders’ Equity |
|||||||||||||||||||||||||||||||
Balance at January 1, 2022 |
$ |
$ |
$ |
— |
$ |
— |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Vesting of restricted shares |
— | — | ( |
) | — | — | — | — | — | |||||||||||||||||||||||||||||||
Issuance of common stock in connection with business combinations |
— | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance at March 31, 2022 |
$ |
$ |
$ |
— |
$ |
— |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||
Vesting of restricted shares |
— | — | ( |
) | — | — | — | — | — | |||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance at June 30, 2022 |
$ |
$ |
$ |
— |
$ |
— |
$ |
( |
) |
$ |
( |
) |
$ |
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
||||||||
June 30 |
June 30 |
|||||||
2023 |
2022 |
|||||||
Cash Flows from operating activities: |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Depreciation and amortization |
||||||||
Loss on disposal of assets |
||||||||
Loss (gain) on fair value remeasurement of contingent consideration |
( |
) | ||||||
Stock-based compensation |
||||||||
Change in fair value of derivative warrant liabilities |
( |
) | ||||||
Non-cash interest expense, net |
||||||||
Non-cash lease expense |
||||||||
Amortization of contract cost |
||||||||
Deferred income taxes |
||||||||
Provision for doubtful accounts |
||||||||
Gain from equity method investment |
( |
) | ( |
) | ||||
Gain on foreign currency remeasurement |
( |
) | ( |
) | ||||
Changes in operating assets and liabilities |
||||||||
Accounts receivable |
( |
) | ||||||
Contract asset |
( |
) | ||||||
Prepaid expenses |
( |
) | ( |
) | ||||
Other current assets |
||||||||
Other assets |
( |
) | ||||||
Accounts payable |
( |
) | ( |
) | ||||
Accrued expenses |
( |
) | ||||||
Deferred revenue |
( |
) | ||||||
Other current liabilities |
( |
) | ||||||
Operating lease liabilities |
( |
) | ( |
) | ||||
Other liabilities |
( |
) | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
Cash flows from investing activities: |
||||||||
Purchases of property and equipment |
( |
) | ( |
) | ||||
Capitalization of internally developed software costs |
( |
) | ( |
) | ||||
Distributions from (contribution to) equity method investments |
( |
) | ||||||
Equity investments without readily determinable fair values |
( |
) | ||||||
Purchases of intangible assets |
( |
) | ||||||
Acquisition of business, net of cash acquired |
( |
) | ||||||
Proceeds from disposal of assets |
||||||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) |
( |
) | ||||
Cash flows from financing activities: |
||||||||
Repayment of loans and mortgage |
( |
) | ||||||
Proceeds from exercise of Public Warrants |
||||||||
Repayment of promissory notes |
( |
) | ||||||
|
|
|
|
|||||
Net cash used in financing activities |
( |
) |
||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
( |
) | ||||||
Net decrease in cash, cash equivalents and restricted cash |
( |
) |
( |
) | ||||
Cash, cash equivalents and restricted cash at beginning of period |
||||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash at end of period |
$ | $ | ||||||
|
|
|
|
|||||
Supplemental disclosure of cash activities: |
||||||||
Cash paid during the period for interest |
$ | ( |
$ | ( |
) | |||
Cash paid during the period for income taxes |
$ | ( |
) | $ | ( |
) | ||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Shares acquired by subsidiary from cashless Public Warrant exercise |
$ | $ | ||||||
Promissory notes arising from equity method investments |
$ | $ | ||||||
Issuance of common stock in connection with business combinations |
$ | $ |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2023 |
2022 |
2023 |
2022 |
|||||||||||||
Revenue by Product Line |
||||||||||||||||
Betting Technology, Content and Services |
$ | |
$ | |
$ | |
$ | |||||||||
Media Technology, Content and Services |
||||||||||||||||
Sports Technology and Services |
||||||||||||||||
Total |
$ |
$ |
$ |
$ |
||||||||||||
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2023 |
2022 |
2023 |
2022 |
|||||||||||||
Revenue by geographical market: |
||||||||||||||||
Europe |
$ | |
$ | |
$ | |
$ | |||||||||
Americas |
||||||||||||||||
Rest of the world |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
June 30, |
December 31, |
|||||||
2023 |
2022 |
|||||||
Cash and cash equivalents |
$ | $ | |
|||||
Restricted cash, current and non-current |
||||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash |
$ |
$ |
||||||
|
|
|
|
Weighted Average Remaining Useful Lives |
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
|||||||||||
(years) |
||||||||||||||
Data rights |
$ | $ | $ | |||||||||||
Marketing products |
||||||||||||||
Technology |
||||||||||||||
Capitalized software |
||||||||||||||
|
|
|
|
|
|
|||||||||
Total intangible assets |
$ |
$ |
$ |
|||||||||||
|
|
|
|
|
|
Weighted Average Remaining Useful Lives |
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
|||||||||||
(years) |
||||||||||||||
Data rights |
$ | $ | $ | |||||||||||
Marketing products |
||||||||||||||
Technology |
||||||||||||||
Capitalized software |
||||||||||||||
|
|
|
|
|
|
|||||||||
Total intangible assets |
$ |
$ |
$ |
|||||||||||
|
|
|
|
|
|
Balance as of December 31, 2022 |
$ | |
||
Effect of currency translation remeasurement |
||||
Balance as of June 30, 2023 |
$ |
|||
June 30, 2023 |
December 31, 2022 |
|||||||
Other current assets: |
||||||||
Non-trade receivables |
$ | $ | ||||||
Inventory |
||||||||
Total other current assets |
$ |
$ |
||||||
Other assets: |
||||||||
Security deposit |
$ | $ | ||||||
Corporate tax receivable |
||||||||
Sales tax receivable |
||||||||
Contract costs |
||||||||
Total other assets |
$ |
$ |
||||||
Instrument |
Date of Issuance |
Maturity Date |
Effective interest rate |
June 30, 2023 |
December 31, 2022 |
|||||||||||||||
Genius Sports Italy Srl Mortgage |
December 2010 | % | $ | $ | ||||||||||||||||
Promissory Note |
January 2022 | % | ||||||||||||||||||
$ | $ | |
||||||||||||||||||
Less current portion of debt |
( |
) | ( |
) | ||||||||||||||||
Non-current portion of debt |
$ |
$ |
||||||||||||||||||
Fiscal Period: |
(in thousands) |
|||
2023 (Remaining) |
$ | |||
2024 |
||||
2025 |
||||
2026 |
||||
2027 |
||||
Thereafter |
||||
Total payment outstanding |
$ |
|||
June 30, |
December 31, |
|||||||
2023 |
2022 |
|||||||
Other current liabilities: |
||||||||
Other payables |
$ | $ | ||||||
Deferred consideration |
||||||||
Contingent consideration |
||||||||
Total other current liabilities |
$ |
$ |
||||||
Three Months ended June 30, |
||||||||
2023 |
2022 |
|||||||
Net loss attributable to common stockholders – basic and diluted |
$ | ( |
) | $ | ( |
) | ||
Basic and diluted weighted average common stock outstanding |
||||||||
Loss per share attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) | ||
Six Months ended June 30, |
||||||||
2023 |
2022 |
|||||||
Net loss attributable to common stockholders – basic and diluted |
$ | ( |
) | $ | ( |
) | ||
Basic and diluted weighted average common stock outstanding |
||||||||
Loss per share attributable to common stockholders – basic and diluted |
$ |
( |
) |
$ |
( |
) | ||
Three and Six Months ended June 30, |
||||||||
2023 |
2022 |
|||||||
Stock options to purchase common stock |
||||||||
Unvested restricted shares |
||||||||
Public and private placement warrants to purchase common stock |
||||||||
Unvested equity-settled restricted share units |
||||||||
Unvested equity-settled performance-based restricted share units |
||||||||
Warrants issued to NFL to purchase common stock |
||||||||
Total |
||||||||
Number of Shares |
Weighted Average Grant Date Fair Value per Share |
|||||||
Unvested restricted shares as of December 31, 2022 |
$ | |||||||
Vested |
( |
) | $ | |||||
Forfeited |
( |
) | $ | |||||
Unvested restricted shares as of June 30, 2023 |
$ |
Number of Options |
Weighted Average Exercise Price |
Weighted Average Remaining Contractual Life |
Aggregate Intrinsic Value |
|||||||||||||
(in years) |
(in thousands) |
|||||||||||||||
Outstanding as of December 31, 2022 |
$ | $ | ||||||||||||||
Forfeited |
( |
) | $ | |||||||||||||
Outstanding as of June 30, 2023 |
$ | $ | ||||||||||||||
Exercisable as of June 30, 2023 |
||||||||||||||||
Unvested as of June 30, 2023 |
Number of RSUs |
Weighted Average Grant Date Fair Value per RSU |
|||||||
Unvested RSUs as of December 31, 2022 |
$ | |||||||
Granted |
$ | |||||||
Forfeited |
( |
) | $ | |||||
Vested |
( |
) | $ | |||||
Unvested RSUs as of June 30, 2023 |
$ |
Number of Cash- settled RSUs |
Weighted Average Grant Date Fair Value per Cash-settled RSU |
|||||||
Unvested Cash-settled RSUs as of December 31, 2022 |
$ | |||||||
Vested |
( |
) | $ | |||||
Unvested Cash-settled RSUs as of June 30, 2023 |
$ |
Time to maturity (1) |
years | |||
Common stock price (2) |
$ | |||
Volatility (3) |
% | |||
Risk-free rate (4) |
% | |||
Dividend yield (5) |
% |
(1) |
Based on contractual terms |
(2) |
Represents the publicly traded common stock price as of the 2022 Grant Date |
(3) |
Calculated based on the Company’s historical volatility over a term of |
(4) |
Based on the U.S. Constant Maturity Treasury yield curve as of the valuation date over a matching term over |
(5) |
Assumes a dividend yield of zero as the Company has no plans to declare dividends in the foreseeable future |
Number of PSUs |
Weighted Average Grant Date Fair Value per PSU |
|||||||
Unvested PSUs as of December 31, 2022 |
$ | |||||||
Granted |
$ | |||||||
Forfeited |
( |
) | $ | |||||
Unvested PSUs as of June 30, 2023 |
$ |
Number of Warrants |
||||
Outstanding as of December 31, 2022 |
||||
Outstanding as of June 30, 2023 |
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2023 |
2022 |
2023 |
2022 |
|||||||||||||
Cost of revenue |
$ | $ | $ | $ | ||||||||||||
Sales and marketing |
||||||||||||||||
Research and development |
||||||||||||||||
General and administrative |
||||||||||||||||
Total |
$ |
$ |
$ |
$ |
||||||||||||
• | Level 1 inputs: Unadjusted quoted prices in active markets for identical assets or liabilities accessible to the reporting entity at the measurement date. |
• | Level 2 inputs: Other than quoted prices included in Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. |
• | Level 3 inputs: Unobservable inputs for the asset or liability used to measure fair value to the extent that observable inputs are not available, thereby allowing for situations in which there is little, if any, market activity for the asset or liability at measurement date. |
Public Warrants |
||||
Derivative warrant liabilities at December 31, 2022 |
$ | |||
Change in fair value |
||||
Exercise of warrants |
( |
) | ||
Foreign currency translation adjustments |
( |
) | ||
Derivative warrant liabilities at June 30, 2023 |
$ |
|||
Description |
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||
Liabilities: |
||||||||||||||||
Contingent Consideration |
$ | $ | $ | $ | ||||||||||||
Total liabilities |
$ |
$ |
$ |
$ |
||||||||||||
2023 |
||||
Beginning balance – January 1 |
$ | |||
Issuance of shares (1) |
( |
) | ||
Loss on fair value remeasurement of contingent consideration (2) |
||||
Foreign currency translation adjustments |
||||
Ending balance – June 30 |
$ |
|||
(1) |
On February 21, 2023, the Company issued |
(2) |
Loss on fair value remeasurement of contingent consideration mainly relates to the Second Spectrum acquisition. |
Three months ended June 30, |
Six months ended June 30, |
|||||||||||||||
2023 |
2022 |
2023 |
2022 |
|||||||||||||
Operating lease cost |
$ | $ | $ | $ | ||||||||||||
Short term lease cost |
||||||||||||||||
Variable lease cost |
||||||||||||||||
Sublease income |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Total lease cost |
$ |
$ |
$ |
$ |
||||||||||||
Six months ended June 30, |
||||||||
2023 |
2022 |
|||||||
Cash paid for amounts included in the measurement of lease liabilities: |
||||||||
Operating cash flows from operating leases |
$ | $ | ||||||
Right-of-use |
||||||||
Weighted-average remaining lease term (in years): |
||||||||
Operating leases |
||||||||
Weighted-average discount rate: |
||||||||
Operating leases |
% | % |
(in thousands) |
||||
2023 (Remaining) |
$ | |||
2024 |
||||
2025 |
||||
2026 |
||||
2027 |
||||
Thereafter |
||||
Total minimum lease payments |
||||
Less: Imputed interest |
( |
) | ||
Present value of lease liabilities |
$ |
|||
Six months ended June 30, |
||||||||
2023 |
2022 |
|||||||
Leases terminated |
||||||||
Right-of-use |
$ | $ | ||||||
Lease liabilities derecognized upon lease termination |
(in thousands) |
||||
2023 (Remaining) |
$ | |||
2024 |
||||
2025 |
||||
2026 |
||||
2027 |
||||
Thereafter |
||||
Total |
$ |
|||